Full-speed mammalian genetics: in vivo target validation in the drug discovery process

Author： Abuin A.   Holt K.H.   Platt K.A.   Sands A.T.   Zambrowicz B.P.  

Publisher： Elsevier

ISSN： 0167-7799

Source： Trends in Biotechnology, Vol.20, Iss.1, 2002-01, pp. : 36-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteomics: drug target discovery on an industrial scale

By Ryan T.E.   Patterson S.D.  

Trends in Biotechnology, Vol. 20, Iss. 12, 2002-12 ,pp. : 45-51

Elsevier

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders

By  

Current Enzyme Inhibition, Vol. 13, Iss. 2, 2017-06 ,pp. : 107-128

Bentham Science Publishers

Access to resources Recommend Favorite

Dual-purpose drug discovery

By Wagner B.K.   Clemons P.A.  

Trends in Biotechnology, Vol. 20, Iss. 12, 2002-12 ,pp. : 492-493

Elsevier

Access to resources Recommend Favorite

Designing combinatorial libraries for drug discovery

By Lobanov V.S.  

Trends in Biotechnology, Vol. 20, Iss. 2, 2002-02 ,pp. : 86-87

Elsevier

Access to resources Recommend Favorite

Using mass spectrometry for drug discovery

By Ong S.-E.   Pandey A.  

Trends in Biotechnology, Vol. 20, Iss. 5, 2002-05 ,pp. : 227-227

Elsevier

Access to resources Recommend Favorite